30-50 % was my talk about sp appreciation, which i still think is real. 70% is the US impression of the drugs chances. As you can see there is quite a mismatch in all these numbers
There are many similar companies in the uS with a few drugs in development and quite a lot of cash. I think this is the 1 year outlook for PYC. 1-2B US mcap, 3 drugs funded thru trials. Many permutations to get there, but US listing is the real key.
PYC Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)